We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 16.28% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Allstate
ALL
$67.1B
| – | – |
-10,423
| Closed | -$956K |
|
|
AMED
302
DELISTED
Amedisys
AMED
| – | – |
-3,745
| Closed | -$687K |
|
303
Atkore
ATKR
$2.53B
| – | – |
-28,045
| Closed | -$591K |
|
304
Avista
AVA
$3.43B
| – | – |
-19,343
| Closed | -$822K |
|
305
Avient
AVNT
$3.33B
| – | – |
-29,493
| Closed | -$559K |
|
306
Armstrong World Industries
AWI
$7.06B
| – | – |
-6,386
| Closed | -$507K |
|
307
Bally's
BALY
$688M
| – | – |
-36,502
| Closed | -$475K |
|
308
Boise Cascade
BCC
$2.74B
| – | – |
-29,477
| Closed | -$701K |
|
309
Bunge Global
BG
$22.8B
| – | – |
-22,279
| Closed | -$914K |
|
310
Buckle
BKE
$2.25B
| – | – |
-41,811
| Closed | -$573K |
|
311
Black Hills Corp
BKH
$5.67B
| – | – |
-22,515
| Closed | -$1.44M |
|
312
BlackLine
BL
$1.82B
| – | – |
-13,612
| Closed | -$716K |
|
313
Pathward Financial
CASH
$1.82B
| – | – |
-28,867
| Closed | -$627K |
|
314
Citizens Financial Group
CFG
$30B
| – | – |
-20,921
| Closed | -$394K |
|
|
315
Chemed
CHE
$6.78B
| – | – |
-4,515
| Closed | -$1.96M |
|
316
Coherus Oncology
CHRS
$227M
| – | – |
-51,487
| Closed | -$835K |
|
317
Cincinnati Financial
CINF
$28.5B
| – | – |
-10,462
| Closed | -$789K |
|
318
CONMED
CNMD
$1.3B
| – | – |
-8,901
| Closed | -$510K |
|
319
Columbia Banking Systems
COLB
$8.78B
| – | – |
-26,972
| Closed | -$723K |
|
320
Costco
COST
$422B
| – | – |
-3,131
| Closed | -$893K |
|
321
Camden Property Trust
CPT
$11.2B
| – | – |
-10,358
| Closed | -$821K |
|
322
Castle Biosciences
CSTL
$729M
| – | – |
-24,581
| Closed | -$733K |
|
323
Cushman & Wakefield Ltd
CWK
$3.07B
| – | – |
-55,503
| Closed | -$652K |
|
324
Douglas Emmett
DEI
$2.04B
| – | – |
-16,027
| Closed | -$489K |
|
325
DHT Holdings
DHT
$2.93B
| – | – |
-110,810
| Closed | -$850K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.